Carasent is delighted to welcome Stefan Jernberg as the group's new Chief Compliance Officer. Stefan brings a wealth of experience and expertise in compliance, having a strong background in software development, MedTech, and extensive knowledge of regulatory frameworks.
HPI, Health Profile Institute, has contributed to a new study conducted at the University of Gothenburg. The study shows that individuals who maintain or increase their fitness have a reduced risk of future hospital admissions, especially if they have previously been hospitalized.
Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to implement the EHR system Metodika EPM at Volvat’s hospitals and clinics in Norway. The annual revenue from the contract is estimated to 7-9 MNOK, where the majority is recurring revenue (“ARR”)
Carasent ASA is set to embark on an exciting new phase as it updates its long-term financial targets for revenue growth and profitability. The detailed presentation will take place today at the Capital Markets Day (CMD).
The board of directors of Carasent ASA has today appointed Daniel Öhman as the Company’s new Chief Executive Officer (CEO). He will succeed Dennis Höjer, who has been CEO since December 2020. Öhman will start no later than 2 January 2023.
Carasent ASA has acquired the Swedish company Medrave Software AB, including its fully-owned Norwegian subsidiary Medrave Software AS (together “Medrave”), a market leader in Scandinavia within quality improvement software for healthcare practices within primary care and secondary outpatient care.
Carasent ASA has acquired the Swedish company Metodika AB (“Metodika”), a leading provider of Enterprise Practice Management (EPM) solutions to independent hospitals and clinics across 10 European countries.